9-methyl-4-(4-(2-(1H-imidazol-1-yl)ethyl)piperazin-1-yl)-pyrrolo[1,2-a]quinoxaline

ID: ALA578809

PubChem CID: 44541940

Max Phase: Preclinical

Molecular Formula: C21H24N6

Molecular Weight: 360.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc2nc(N3CCN(CCn4ccnc4)CC3)c3cccn3c12

Standard InChI:  InChI=1S/C21H24N6/c1-17-4-2-5-18-20(17)27-8-3-6-19(27)21(23-18)26-14-12-24(13-15-26)10-11-25-9-7-22-16-25/h2-9,16H,10-15H2,1H3

Standard InChI Key:  PJNPXONFXSTOIP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   10.1966  -17.2455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2123  -18.0663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9997  -18.3081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4730  -17.6339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9780  -16.9755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7675  -13.5404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7663  -14.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4799  -14.7786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4781  -13.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1923  -13.5367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1957  -14.3685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9138  -14.7791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6330  -14.3626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9070  -13.1156    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6301  -13.5328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2503  -12.9740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9104  -12.2114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0803  -12.2991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3473  -14.7727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3463  -15.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0565  -16.0109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7712  -15.6008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7712  -14.7762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0565  -14.3616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4839  -16.0136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4828  -16.8373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4757  -12.3046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
 13 15  1  0
 14 15  1  0
  6  7  2  0
  2  3  2  0
  7  8  1  0
  8 11  2  0
  3  4  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 10  9  2  0
 13 19  1  0
 19 20  1  0
  9  6  1  0
 10 11  1  0
  4  5  2  0
  5  1  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  1  2  1  0
 22 25  1  0
 10 14  1  0
 25 26  1  0
 26  1  1  0
 11 12  1  0
  9 27  1  0
M  END

Associated Targets(non-human)

Htr3a Serotonin 3a (5-HT3a) receptor (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.47Molecular Weight (Monoisotopic): 360.2062AlogP: 2.81#Rotatable Bonds: 4
Polar Surface Area: 41.60Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.77CX LogP: 2.77CX LogD: 2.25
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -1.69

References

1. Butini S, Budriesi R, Hamon M, Morelli E, Gemma S, Brindisi M, Borrelli G, Novellino E, Fiorini I, Ioan P, Chiarini A, Cagnotto A, Mennini T, Fracasso C, Caccia S, Campiani G..  (2009)  Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization.,  52  (21): [PMID:19831400] [10.1021/jm901126m]

Source